Latest news with #WMTechnology
Yahoo
6 days ago
- Business
- Yahoo
Blade Air Mobility And 2 Other Promising Penny Stocks To Watch
As the U.S. stock market experiences fluctuations, with recent inflation data affecting rate-cut expectations and major indices like the S&P 500 reaching new highs, investors are exploring diverse opportunities. Penny stocks, often representing smaller or newer companies, continue to attract attention due to their potential for value and growth despite their vintage moniker. In this article, we explore three penny stocks that stand out for their financial resilience and potential long-term promise in today's market landscape. Top 10 Penny Stocks In The United States Name Share Price Market Cap Financial Health Rating ATRenew (RERE) $4.24 $1.01B ★★★★★★ Waterdrop (WDH) $1.80 $661.84M ★★★★★★ WM Technology (MAPS) $1.25 $216.34M ★★★★★★ Performance Shipping (PSHG) $1.87 $23.62M ★★★★★★ Tuniu (TOUR) $0.9326 $96.78M ★★★★★★ BAB (BABB) $0.94 $6.75M ★★★★★★ Lifetime Brands (LCUT) $3.90 $89.5M ★★★★★☆ Marine Petroleum Trust (MARP.S) $4.28 $8.62M ★★★★★☆ Resources Connection (RGP) $4.72 $164.37M ★★★★★★ TETRA Technologies (TTI) $3.96 $522.46M ★★★★★★ Click here to see the full list of 395 stocks from our US Penny Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. Blade Air Mobility Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Blade Air Mobility, Inc. offers air transportation and logistics services for hospitals both in the United States and internationally, with a market cap of approximately $358.64 million. Operations: The company's revenue is divided into two main segments: Medical services, generating $153.51 million, and Passenger services, contributing $100.84 million. Market Cap: $358.64M Blade Air Mobility, Inc. has been navigating a challenging landscape as an unprofitable company with increasing losses over the past five years. However, it remains debt-free and possesses a substantial cash runway exceeding three years, which could provide stability amid its financial struggles. Recent earnings reports indicate a narrowing net loss for the second quarter of 2025 at US$3.74 million compared to US$11.33 million the previous year, alongside modest revenue growth in both medical and passenger services segments. Potential acquisition talks with Joby Aviation highlight strategic interest in Blade's market position despite its current financial difficulties. Click here and access our complete financial health analysis report to understand the dynamics of Blade Air Mobility. Understand Blade Air Mobility's earnings outlook by examining our growth report. Information Services Group Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Information Services Group, Inc. is an AI-focused technology research and advisory firm operating across the Americas, Europe, and the Asia Pacific with a market cap of approximately $242.91 million. Operations: The company generates revenue from its Fact-Based Sourcing Advisory Services, totaling $240.20 million. Market Cap: $242.91M Information Services Group, Inc. has shown resilience as it navigates the competitive landscape of technology advisory services. The company reported US$61.57 million in Q2 2025 sales, slightly down from the previous year, yet net income rose to US$2.18 million from US$2.04 million, illustrating improved profitability despite revenue fluctuations. With its debt well-covered by operating cash flow and a satisfactory net debt to equity ratio of 36.1%, ISG maintains financial stability while actively engaging in strategic initiatives like share buybacks and dividend distributions, enhancing shareholder value amid ongoing digital transformation efforts across various industries. Navigate through the intricacies of Information Services Group with our comprehensive balance sheet health report here. Evaluate Information Services Group's prospects by accessing our earnings growth report. loanDepot Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: loanDepot, Inc. operates in the United States by originating, financing, selling, and servicing residential mortgage loans and has a market cap of approximately $658.54 million. Operations: The company generates revenue of $1.12 billion from the originating, financing, and selling of mortgage loans. Market Cap: $658.54M loanDepot faces challenges as it remains unprofitable, with a net loss of US$13.39 million in Q2 2025, although this is an improvement from the previous year. The company has a high net debt to equity ratio of 1095.6%, indicating significant leverage concerns, but its short-term assets exceed both short and long-term liabilities. Recent executive changes aim to drive growth and return to profitability, including appointing Anthony Hsieh as CEO and promoting Tom Fiddler and Dan Peña to key leadership roles. Despite volatility in share price, loanDepot's inclusion in multiple Russell indices could enhance visibility among investors. Dive into the specifics of loanDepot here with our thorough balance sheet health report. Gain insights into loanDepot's outlook and expected performance with our report on the company's earnings estimates. Summing It All Up Unlock more gems! Our US Penny Stocks screener has unearthed 392 more companies for you to here to unveil our expertly curated list of 395 US Penny Stocks. Ready For A Different Approach? Uncover 15 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BLDE III and LDI. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
24-07-2025
- Business
- Yahoo
WM Technology, Inc. to Announce Second Quarter 2025 Financial Results via Webcast
IRVINE, Calif., July 24, 2025--(BUSINESS WIRE)--WM Technology, Inc. ("WM Technology" or the "Company") (Nasdaq: MAPS), a leading marketplace and technology solutions provider to the cannabis industry, today announced it will report financial results for its second quarter ended June 30, 2025 after market close on Thursday, August 7, 2025. Management will host a webcast to discuss the Company's financial results at 2 p.m. Pacific Time (or 5 p.m. Eastern Time) on the same day. A replay of the call will be available at by the end of the day August 8. WM Technology Second Quarter 2025 Financial Results Webcast When Thursday, August 7, 2025 Time 2 p.m. PT / 5 p.m. ET Webcast Link Replay webcast replay will be archived on this site August 8. About WM Technology Founded in 2008, WM Technology operates Weedmaps, the leading cannabis marketplace for consumers, as well as a set of eCommerce and compliance software solutions for cannabis businesses and brands. WM Technology holds a strong belief in the power of cannabis and the importance of enabling safe, legal access to consumers worldwide. Over the past 15 years, the Weedmaps marketplace has become the premier destination for cannabis consumers to discover and browse cannabis-related products, access daily dispensary deals, order ahead for pick-up and delivery (where applicable), and learn about the plant. The Company also offers eCommerce-enablement tools designed to help cannabis retailers and brands reach consumers, create business efficiency, and manage industry-specific compliance needs. The Company is committed to advocating for full U.S. legalization, industry-wide social equity, and continued education about the plant through key partnerships and cannabis subject matter experts. Headquartered in Irvine, California, WM Technology supports remote and hybrid work for eligible employees. Visit us at View source version on Contacts Media: press@ Investor Relations: investors@ Error in retrieving data Sign in to access your portfolio Error in retrieving data
Business Wire
24-07-2025
- Business
- Business Wire
WM Technology, Inc. to Announce Second Quarter 2025 Financial Results via Webcast
IRVINE, Calif.--(BUSINESS WIRE)--WM Technology, Inc. ('WM Technology' or the 'Company') (Nasdaq: MAPS), a leading marketplace and technology solutions provider to the cannabis industry, today announced it will report financial results for its second quarter ended June 30, 2025 after market close on Thursday, August 7, 2025. Management will host a webcast to discuss the Company's financial results at 2 p.m. Pacific Time (or 5 p.m. Eastern Time) on the same day. A replay of the call will be available at by the end of the day August 8. About WM Technology Founded in 2008, WM Technology operates Weedmaps, the leading cannabis marketplace for consumers, as well as a set of eCommerce and compliance software solutions for cannabis businesses and brands. WM Technology holds a strong belief in the power of cannabis and the importance of enabling safe, legal access to consumers worldwide. Over the past 15 years, the Weedmaps marketplace has become the premier destination for cannabis consumers to discover and browse cannabis-related products, access daily dispensary deals, order ahead for pick-up and delivery (where applicable), and learn about the plant. The Company also offers eCommerce-enablement tools designed to help cannabis retailers and brands reach consumers, create business efficiency, and manage industry-specific compliance needs. The Company is committed to advocating for full U.S. legalization, industry-wide social equity, and continued education about the plant through key partnerships and cannabis subject matter experts. Headquartered in Irvine, California, WM Technology supports remote and hybrid work for eligible employees. Visit us at
Yahoo
29-06-2025
- Business
- Yahoo
Nautilus Biotechnology Leads The Pack In Our Top 3 Penny Stocks
Over the last 7 days, the United States market has risen by 2.7%, and over the past year, it is up by 13%, with earnings expected to grow annually by 15% in the coming years. In light of these conditions, investors might find value in penny stocks—typically smaller or newer companies—that can offer growth opportunities when backed by strong financial health. Though considered a niche area today, penny stocks remain relevant for those seeking potential hidden value and long-term gains; here we explore three such stocks that combine balance sheet resilience with promising prospects. Name Share Price Market Cap Financial Health Rating Waterdrop (WDH) $1.35 $488.24M ★★★★★★ WM Technology (MAPS) $0.9265 $148M ★★★★★★ Tuniu (TOUR) $0.9326 $95.14M ★★★★★★ Safe Bulkers (SB) $3.66 $376.5M ★★★★☆☆ Golden Growers Cooperative (GGRO.U) $5.00 $77.45M ★★★★★★ Flexible Solutions International (FSI) $4.50 $55.08M ★★★★★★ BAB (BABB) $0.8339 $6.1M ★★★★★★ Lifetime Brands (LCUT) $3.77 $86.97M ★★★★★☆ Marine Petroleum Trust (MARP.S) $4.43 $8.76M ★★★★★☆ TETRA Technologies (TTI) $3.46 $441.8M ★★★★☆☆ Click here to see the full list of 449 stocks from our US Penny Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Nautilus Biotechnology, Inc. is a development stage life sciences company focused on creating a platform technology to quantify and unlock the complexity of the proteome, with a market cap of approximately $100.09 million. Operations: Nautilus Biotechnology has not reported any revenue segments. Market Cap: $100.09M Nautilus Biotechnology, with a market cap of US$100.09 million, is a pre-revenue life sciences company facing challenges typical of penny stocks. It recently received notice from Nasdaq for not meeting the minimum bid price requirement but has until October 28, 2025, to regain compliance. Despite being debt-free and having short-term assets exceeding liabilities significantly (US$141.6 million vs. US$33.3 million), the company remains unprofitable with losses increasing at an annual rate of 20.5% over five years and no profitability forecast in the near term. Revenue is expected to grow substantially, yet earnings are projected to decline by 8.5% annually over three years. Jump into the full analysis health report here for a deeper understanding of Nautilus Biotechnology. Assess Nautilus Biotechnology's future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: BARK, Inc. is a dog-centric company offering products, services, and content for dogs with a market cap of approximately $144.50 million. Operations: The company's revenue is derived from two primary segments: Commerce, which generated $68.35 million, and Direct to Consumer, contributing $415.84 million. Market Cap: $144.5M BARK, Inc., with a market cap of US$144.50 million, is navigating the challenges typical of penny stocks with a focus on dog-centric products and services. Despite being unprofitable and not expected to achieve profitability in the next three years, BARK has shown financial improvements; its short-term assets exceed both short-term and long-term liabilities significantly. Recent earnings revealed a slight decline in sales to US$484.18 million for the year ended March 31, 2025, while losses have narrowed compared to the previous year. The company anticipates lower first-quarter revenue due to reduced marketing efforts amid uncertain macro conditions. Click here and access our complete financial health analysis report to understand the dynamics of BARK. Learn about BARK's future growth trajectory here. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Seritage Growth Properties is a company focused on the ownership, development, redevelopment, management, sale and leasing of diversified retail and mixed-use properties across the United States with a market cap of approximately $165.59 million. Operations: The company's revenue segment primarily involves real estate properties, which generated -$3.41 million. Market Cap: $165.59M Seritage Growth Properties, with a market cap of US$165.59 million, is navigating the complexities of penny stocks in the real estate sector. Despite ongoing unprofitability and declining earnings over five years, its short-term assets of US$123.1 million exceed short-term liabilities significantly but fall short against long-term liabilities of US$240 million. The company has reduced its debt substantially from 157.9% to 62.8% over five years and recently made a voluntary prepayment on its term loan facility, reducing annual interest expenses by approximately US$99.4 million since December 2021 while pursuing a strategic Plan of Sale reducing its portfolio to 15 assets from approximately 160 since March 2022. Click to explore a detailed breakdown of our findings in Seritage Growth Properties' financial health report. Review our historical performance report to gain insights into Seritage Growth Properties' track record. Investigate our full lineup of 449 US Penny Stocks right here. Interested In Other Possibilities? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NAUT BARK and SRG. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Erreur lors de la récupération des données Connectez-vous pour accéder à votre portefeuille Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données
Yahoo
26-06-2025
- Business
- Yahoo
June 2025's Promising Penny Stocks
Over the last 7 days, the U.S. market has risen by 1.7%, and over the past year, it is up 12%, with earnings forecasted to grow by 15% annually. In light of these conditions, identifying stocks that offer both value and growth potential becomes crucial for investors seeking opportunities in smaller companies. Penny stocks, although an outdated term, continue to represent a segment of the market where smaller or newer companies can provide promising investment prospects when backed by strong financials. Name Share Price Market Cap Financial Health Rating Waterdrop (WDH) $1.35 $502.71M ★★★★★★ WM Technology (MAPS) $0.88 $156.24M ★★★★★★ Tuniu (TOUR) $0.9326 $94.77M ★★★★★★ Safe Bulkers (SB) $3.68 $380.59M ★★★★☆☆ Golden Growers Cooperative (GGRO.U) $5.00 $77.45M ★★★★★★ Flexible Solutions International (FSI) $4.355 $55.27M ★★★★★★ BAB (BABB) $0.8399 $6.06M ★★★★★★ Lifetime Brands (LCUT) $3.88 $88.98M ★★★★★☆ Marine Petroleum Trust (MARP.S) $4.38 $9.92M ★★★★★☆ TETRA Technologies (TTI) $3.32 $459.1M ★★★★☆☆ Click here to see the full list of 447 stocks from our US Penny Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Fuel Tech, Inc. focuses on developing and applying technologies for air pollution control, process optimization, and water treatment, with a market cap of $72.33 million. Operations: The company generates revenue from two main segments: Fuel Chem, which contributes $16.33 million, and Air Pollution Control, which adds $10.23 million. Market Cap: $72.33M Fuel Tech, Inc., a company with a market cap of US$72.33 million, operates in the air pollution control and process optimization sectors. Despite reporting Q1 2025 sales of US$6.38 million, an increase from the previous year, it remains unprofitable with a net loss of US$0.739 million for the same period. The company's seasoned management and board provide stability amidst high share price volatility over recent months. Fuel Tech is debt-free and its short-term assets significantly exceed liabilities, offering financial flexibility as it continues to secure new contracts in both domestic and international markets for its pollution control technologies. Navigate through the intricacies of Fuel Tech with our comprehensive balance sheet health report here. Assess Fuel Tech's future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: I-Mab is a biotech company specializing in the development of immuno-oncology agents for cancer treatment in the United States, with a market cap of $193.54 million. Operations: There are currently no reported revenue segments for the company. Market Cap: $193.54M I-Mab, with a market cap of US$193.54 million, is pre-revenue and remains unprofitable. Despite this, it has made significant strides in reducing its net loss from US$207.73 million to US$22.23 million over the past year. The company recently regained compliance with Nasdaq's minimum bid price requirement, ensuring continued trading on the exchange. I-Mab benefits from a strong liquidity position with short-term assets of US$173.2 million exceeding both short and long-term liabilities significantly, while also being debt-free. However, its share price has been highly volatile recently and earnings are forecasted to decline by 10.4% annually over the next three years. Jump into the full analysis health report here for a deeper understanding of I-Mab. Gain insights into I-Mab's future direction by reviewing our growth report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing oral antiviral therapeutics for serious viral infections, with a market cap of $289.26 million. Operations: Atea Pharmaceuticals has not reported any revenue segments. Market Cap: $289.26M Atea Pharmaceuticals, with a market cap of US$289.26 million, is pre-revenue and unprofitable. The company recently initiated the global Phase 3 C-FORWARD trial for its HCV treatment regimen, following successful Phase 2 results showing high efficacy and safety. Despite not generating revenue yet, Atea maintains a strong liquidity position with short-term assets of US$433.7 million far exceeding liabilities and remains debt-free. Recent shareholder activism led to board changes aimed at enhancing strategic decision-making. Atea's share repurchase program worth up to US$25 million reflects confidence in its long-term prospects while continuing to fund clinical developments. Dive into the specifics of Atea Pharmaceuticals here with our thorough balance sheet health report. Understand Atea Pharmaceuticals' earnings outlook by examining our growth report. Unlock our comprehensive list of 447 US Penny Stocks by clicking here. Ready To Venture Into Other Investment Styles? The end of cancer? These 24 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include FTEK IMAB and AVIR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
